Lachman Consultants Names Compliance Services VP

Mary Oates has been appointed vice president of Compliance Services, Lachman Consultants, Inc.  In her role, Ms. Oates will lead Lachman’s Compliance Practice Group, bringing a client-side perspective on a broad range of compliance matters to the firm’s international clientele.
 
Ms. Oates has held a series of ascending leadership roles since she began her career as a senior scientist for Glaxo Inc. in 1990. In 1994, she joined Warner Lambert, moving up as director of the Quality Design Department. When Warner Lambert was acquired by Pfizer Inc. in 2000, she remained with the organization, taking on leadership positions in Quality and Regulatory Affairs over the next 18 years.
 
She also served as head of Global Quality Operations and as vice president of Innovative Operations and Network Excellence. In this capacity, Oates was responsible for the supply of all consumer healthcare products, internal biological manufacturing and global implementation of lean manufacturing across the Pfizer network.
 
"It is exciting to add someone to our team who has managed quality and compliance for one of the world’s largest pharmaceutical organizations," said Fran Zipp, president and chief executive officer of Lachman Consultants, Inc. "I’ve known Mary for many years, and her record of achievement speaks for itself. As a vocal advocate of driving excellence in quality systems, processes and cultures, she has always kept the betterment of the patient in mind. In addition to a broad range of experiences, her client-side perspective will give our clients a measure of added assurance." 

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.